Skip to content
Disclosery

Broadfin Capital, LLC

Follow

13F filer, CIK 1511901, New York, NY

Broadfin Capital, LLC reported $746,813,000 across 40 holdings for the quarter ended 2019-12-31, in a 13F-HR filed 2020-02-14. Its ten largest share positions make up 50.05% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001511901-20-000003

Period
2019-12-31
Reported value
$747M
Holdings
40
Top 10 weight
50.05%
New
12
Sold out
16

Largest buys vs the previous quarter

SecurityShares changeApprox. value
STAAnew+462,118$16.3M
ALKSadded+784,500$16M
QUOTIENT LTDadded+1,380,754$13.1M
LNTHnew+617,953$12.7M
NANOSTRING TECHNOLOGIES INCadded+444,800$12.4M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
IOVAreduced-597,800-$16.5M
ALLERGAN PLCexited-96,504-$16.2M
AVADEL PHARMACEUTICALS, PLCreduced-2,073,661-$15.7M
NEVRO CORPexited-150,510-$12.9M
WRIGHT MED GROUP N Vexited-618,500-$12.8M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2019

Share positions as resolved from 13F-HR 0001511901-20-000003, largest first. % of portfolio is the value over $402,626,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
BIODELIVERY SCIENCES INTL INBIODELIVERY SCIENCES INTL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: 4,278,819 shares; 2018Q2: 4,278,819 shares; 2018Q3: 4,375,066 shares; 2018Q4: 4,375,066 shares; 2019Q1: 4,375,066 shares; 2019Q2: 4,281,943 shares; 2019Q3: 4,300,066 shares; 2019Q4: 4,300,066 shares 4,300,066$27.2M6.75%0
VRAYQVIEWRAY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 250,000 shares; 2018Q4: 866,500 shares; 2019Q1: 866,500 shares; 2019Q2: 866,500 shares; 2019Q3: 3,001,361 shares; 2019Q4: 5,574,366 shares 5,574,366$23.5M5.84%+2,573,005Timeline
AMARIN CORP PLCAMARIN CORP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: 2,078,799 shares; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: 291,000 shares; 2019Q3: 1,569,011 shares; 2019Q4: 1,049,244 shares 1,049,244$22.5M5.59%-519,767
BIOHAVEN PHARMACEUTICAL HOL…BIOHAVEN PHARMACEUTICAL HOLDINQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: 129,300 shares; 2019Q1: 246,900 shares; 2019Q2: 676,879 shares; 2019Q3: 532,591 shares; 2019Q4: 409,338 shares 409,338$22.3M5.53%-123,253
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: 249,000 shares; 2019Q4: 1,033,500 shares 1,033,500$21.1M5.24%+784,500Timeline
QUOTIENT LTDQUOTIENT LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not reported; 2018Q2: 439,700 shares; 2018Q3: 804,700 shares; 2018Q4: 1,697,582 shares; 2019Q1: 1,098,656 shares; 2019Q2: 639,756 shares; 2019Q3: 613,429 shares; 2019Q4: 1,994,183 shares 1,994,183$19M4.71%+1,380,754
EIGER BIOPHARMACEUTICALS INCEIGER BIOPHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: 143,300 shares; 2019Q1: 193,300 shares; 2019Q2: 1,656,137 shares; 2019Q3: 1,367,377 shares; 2019Q4: 1,236,368 shares 1,236,368$18.4M4.58%-131,009
STAASTAAR SURGICAL COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: not reported; 2019Q4: 462,118 shares 462,118$16.3M4.04%newTimeline
INTERSECT ENT INCINTERSECT ENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 234,200 shares; 2018Q4: 287,900 shares; 2019Q1: 263,500 shares; 2019Q2: not reported; 2019Q3: 779,134 shares; 2019Q4: 631,023 shares 631,023$15.7M3.9%-148,111
PROGENICS PHARMACEUTICALS INPROGENICS PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: 1,583,925 shares; 2019Q4: 3,060,923 shares 3,060,923$15.6M3.87%+1,476,998
NANOSTRING TECHNOLOGIES INCNANOSTRING TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: 850,000 shares; 2018Q4: 720,600 shares; 2019Q1: 355,714 shares; 2019Q2: 74,786 shares; 2019Q3: 110,800 shares; 2019Q4: 555,600 shares 555,600$15.5M3.84%+444,800
IOVAIOVANCE BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: 912,987 shares; 2018Q2: 4,146,605 shares; 2018Q3: 4,894,361 shares; 2018Q4: 5,951,153 shares; 2019Q1: 4,328,303 shares; 2019Q2: 1,559,299 shares; 2019Q3: 1,131,101 shares; 2019Q4: 533,301 shares 533,301$14.8M3.67%-597,800Timeline
DERMIRA INCDERMIRA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: 579,600 shares; 2019Q4: 896,334 shares 896,334$13.6M3.37%+316,734
SOCIETAL CDMO INCSOCIETAL CDMO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: 2,236,025 shares; 2018Q2: 2,048,025 shares; 2018Q3: 2,048,025 shares; 2018Q4: 2,048,025 shares; 2019Q1: 1,909,995 shares; 2019Q2: 1,561,617 shares; 2019Q3: 987,760 shares; 2019Q4: 721,073 shares 721,073$13.2M3.28%-266,687
LNTHLANTHEUS HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: not reported; 2019Q4: 617,953 shares 617,953$12.7M3.15%newTimeline
VAPOTHERM INCVAPOTHERM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: not reported; 2019Q4: 1,003,099 shares 1,003,099$12.2M3.03%new
SIENTRA INCSIENTRA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: 1,400,000 shares; 2019Q3: 2,001,895 shares; 2019Q4: 1,286,987 shares 1,286,987$11.5M2.86%-714,908
VCELVERICEL CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: 658,900 shares; 2018Q2: not reported; 2018Q3: 132,600 shares; 2018Q4: 190,000 shares; 2019Q1: 272,550 shares; 2019Q2: 258,150 shares; 2019Q3: 237,050 shares; 2019Q4: 620,199 shares 620,199$10.8M2.68%+383,149Timeline
LA JOLLA PHARMACEUTICAL COLA JOLLA PHARMACEUTICAL COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: 1,656,720 shares; 2018Q2: 1,494,520 shares; 2018Q3: 2,053,991 shares; 2018Q4: 1,947,541 shares; 2019Q1: 1,994,911 shares; 2019Q2: 891,760 shares; 2019Q3: 181,844 shares; 2019Q4: 2,688,068 shares 2,688,068$10.6M2.62%+2,506,224
ALEXION PHARMACEUTICALS INCALEXION PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: 58,700 shares; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: not reported; 2019Q4: 83,100 shares 83,100$8.99M2.23%new
SOL GEL TECHNOLOGIESSOL GEL TECHNOLOGIESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: 647,700 shares; 2018Q2: 647,700 shares; 2018Q3: 847,700 shares; 2018Q4: 847,700 shares; 2019Q1: 847,700 shares; 2019Q2: 730,100 shares; 2019Q3: 563,300 shares; 2019Q4: 521,819 shares 521,819$8.95M2.22%-41,481
RLMDRELMADA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: not reported; 2019Q4: 220,724 shares 220,724$8.61M2.14%newTimeline
AUPHAURINIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: not reported; 2019Q4: 400,000 shares 400,000$8.1M2.01%newTimeline
AVADEL PHARMACEUTICALS, PLCAVADEL PHARMACEUTICALS, PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: 2,624,663 shares; 2018Q2: 2,724,663 shares; 2018Q3: 2,792,773 shares; 2018Q4: 3,102,673 shares; 2019Q1: 3,102,673 shares; 2019Q2: 3,102,673 shares; 2019Q3: 3,102,673 shares; 2019Q4: 1,029,012 shares 1,029,012$7.77M1.93%-2,073,661
EXICURE INCEXICURE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: 2,311,906 shares; 2019Q4: 2,707,851 shares 2,707,851$7.74M1.92%+395,945
ZOGENIX INC.ZOGENIX INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: 537,380 shares; 2018Q2: 622,380 shares; 2018Q3: 657,898 shares; 2018Q4: 535,998 shares; 2019Q1: 371,698 shares; 2019Q2: 344,762 shares; 2019Q3: 138,037 shares; 2019Q4: 134,937 shares 134,937$7.03M1.75%-3,100
ICUIICU MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: 30,000 shares; 2019Q4: 30,000 shares 30,000$5.61M1.39%0Timeline
LUMINEX CORPLUMINEX CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: not reported; 2019Q4: 207,553 shares 207,553$4.81M1.19%new
STRATA SKIN SCIENCES INCSTRATA SKIN SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: 203,346 shares; 2018Q2: 2,943,819 shares; 2018Q3: 2,181,363 shares; 2018Q4: 2,171,363 shares; 2019Q1: 2,866,323 shares; 2019Q2: 3,256,615 shares; 2019Q3: 2,916,915 shares; 2019Q4: 1,839,372 shares 1,839,372$3.83M0.95%-1,077,543
ANABANAPTYSBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: 79,200 shares; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: not reported; 2019Q4: 221,600 shares 221,600$3.6M0.89%newTimeline
ACRSACLARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: 1,877,502 shares; 2019Q1: 2,030,925 shares; 2019Q2: not reported; 2019Q3: 1,620,000 shares; 2019Q4: 1,888,039 shares 1,888,039$3.57M0.89%+268,039Timeline
MYLAN NVMYLAN NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: not reported; 2019Q4: 150,000 shares 150,000$3.02M0.75%new
HRTXHERON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: 1,581,416 shares; 2018Q2: 519,787 shares; 2018Q3: 291,213 shares; 2018Q4: 119,294 shares; 2019Q1: 207,998 shares; 2019Q2: 657,998 shares; 2019Q3: 98,237 shares; 2019Q4: 89,730 shares 89,730$2.11M0.52%-8,507Timeline
SCYNEXIS INC COM NEWSCYNEXIS INC COM NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: 1,885,904 shares; 2018Q2: 1,885,904 shares; 2018Q3: 1,885,904 shares; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: not reported; 2019Q4: 2,000,000 shares 2,000,000$1.82M0.45%new
PALATIN TECHNOLOGIES INCPALATIN TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2018Q1: not reported; 2018Q2: not reported; 2018Q3: not reported; 2018Q4: not reported; 2019Q1: not reported; 2019Q2: not reported; 2019Q3: 1,047,310 shares; 2019Q4: 1,047,310 shares 1,047,310$819K0.2%0

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
SPYSTATE STR SPDR S&P 500 ETF T SHSput440,000$142M0
IWMISHARES TR SHSput800,000$133Mnew
XBISPDR SERIES TRUST S&P BIOTECHput350,000$33.3M-350,000
BIOHAVEN PHARMACEUTICAL HOL…BIOHAVEN PHARMACEUTICAL HOLDIN COMcall600,000$32.7M+100,000
ALKSALKERMES PLC SHScall200,000$4.08Mnew

Sold out in Q4 2019

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
ALLERGAN PLCALLERGAN PLC96,504$16.2Mshares
MIRATI THERAPEUTICS INCMIRATI THERAPEUTICS INC200,000$15.6Mcall
NEVRO CORPNEVRO CORP150,510$12.9Mshares
WRIGHT MED GROUP N VWRIGHT MED GROUP N V618,500$12.8Mshares
ABBVABBVIE INC154,500$11.7Mshares
GLOBAL BLOOD THERAPEUTICS U…GLOBAL BLOOD THERAPEUTICS USD177,016$8.59Mshares
RETROPHIN INCRETROPHIN INC610,414$7.08Mshares
STRONGBRIDGE BIOPHARMA PLCSTRONGBRIDGE BIOPHARMA PLC2,578,003$6.16Mshares
XGNEXAGEN INC311,284$4.82Mshares
CPRXCATALYST PHARMACEUTICALS INC880,303$4.67Mshares
ANTARES PHARMA INCANTARES PHARMA INC1,336,700$4.47Mshares
SIBNSI BONE INC223,291$3.95Mshares
GW PHARMACEUTICALS PLCGW PHARMACEUTICALS PLC30,000$3.45Mshares
ADMAADMA BIOLOGICS INC505,900$2.25Mshares
HRTXHERON THERAPEUTICS INC100,000$1.85Mcall
AMAG PHARMACEUTICALS INCAMAG PHARMACEUTICALS INC100,000$1.16Mshares

How Q4 2019 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001511901-20-000003 base2020-02-14acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001511901-20-000003 Quarter ended 2019-12-312020-02-14acceptance time not in the bulk data set
13F-HR 0001511901-19-000006 Quarter ended 2019-09-302019-11-14acceptance time not in the bulk data set
13F-HR 0001511901-19-000005 Quarter ended 2019-06-302019-08-14acceptance time not in the bulk data set
13F-HR 0001511901-19-000004 Quarter ended 2019-03-312019-05-15acceptance time not in the bulk data set
13F-HR 0001511901-19-000001 Quarter ended 2018-12-312019-02-14acceptance time not in the bulk data set
13F-HR 0001511901-18-000006 Quarter ended 2018-09-302018-11-14acceptance time not in the bulk data set
13F-HR 0001511901-18-000005 Quarter ended 2018-06-302018-08-14acceptance time not in the bulk data set
13F-HR 0001511901-18-000003 Quarter ended 2018-03-312018-05-14acceptance time not in the bulk data set
13F-HR 0001511901-18-000002 Quarter ended 2017-12-312018-02-13acceptance time not in the bulk data set
13F-HR 0001511901-17-000008 Quarter ended 2017-09-302017-11-14acceptance time not in the bulk data set
13F-HR/A 0001511901-17-000007 Quarter ended 2017-06-302017-08-17acceptance time not in the bulk data set
13F-HR 0001511901-17-000005 Quarter ended 2017-06-302017-08-14acceptance time not in the bulk data set
13F-HR 0001511901-17-000002 Quarter ended 2017-03-312017-05-15acceptance time not in the bulk data set
13F-HR 0000919574-17-001744 Quarter ended 2016-12-312017-02-14acceptance time not in the bulk data set
13F-HR 0000919574-16-016379 Quarter ended 2016-09-302016-11-14acceptance time not in the bulk data set
13F-HR 0000919574-16-014878 Quarter ended 2016-06-302016-08-15acceptance time not in the bulk data set
13F-HR 0000919574-16-013079 Quarter ended 2016-03-312016-05-16acceptance time not in the bulk data set
13F-HR 0000919574-16-010850 Quarter ended 2015-12-312016-02-16acceptance time not in the bulk data set
13F-HR/A 0000919574-15-008334 Quarter ended 2015-09-302015-11-20acceptance time not in the bulk data set
13F-HR 0000919574-15-008239 Quarter ended 2015-09-302015-11-16acceptance time not in the bulk data set
13F-HR 0000919574-15-006089 Quarter ended 2015-06-302015-08-14acceptance time not in the bulk data set
13F-HR 0000919574-15-004356 Quarter ended 2015-03-312015-05-15acceptance time not in the bulk data set
13F-HR 0000919574-15-002032 Quarter ended 2014-12-312015-02-17acceptance time not in the bulk data set
13F-HR/A 0000919574-15-002293 Quarter ended 2014-12-312015-02-17acceptance time not in the bulk data set
13F-HR 0000919574-14-006641 Quarter ended 2014-09-302014-11-14acceptance time not in the bulk data set
13F-HR/A 0000919574-14-004925 Quarter ended 2014-06-302014-08-22acceptance time not in the bulk data set
13F-HR 0000919574-14-004694 Quarter ended 2014-06-302014-08-14acceptance time not in the bulk data set
13F-HR 0000919574-14-003378 Quarter ended 2014-03-312014-05-15acceptance time not in the bulk data set
13F-HR/A 0000919574-14-002012 Quarter ended 2013-12-312014-02-28acceptance time not in the bulk data set
13F-HR 0000919574-14-001010 Quarter ended 2013-12-312014-02-14acceptance time not in the bulk data set
13F-HR 0000919574-13-006678 Quarter ended 2013-09-302013-11-14acceptance time not in the bulk data set
13F-HR 0000919574-13-004769 Quarter ended 2013-06-302013-08-14acceptance time not in the bulk data set